Comparative analysis of in vitro rat liver metabolism of the antimalarial primaquine and a derived imidazoquine

Drug Metabolism Letters

Volumn 6, Issue 1, 2012, Pages 15-25

  Vale, Nuno ^a   Fernandes, Iva ^a   Moreira, Rui ^b   Mateus, Nuno ^a   Gomes, Paula ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Drug metabolism; Imidazoquines; Malaria; Microsomes; Peptidomimetic; Primaquine; Vivax

Indexed keywords

IMIDAZOQUINE; PRIMAQUINE; PRIMAQUINE DERIVATIVE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; DRUG DERIVATIVE; IMIDAZOLIDINE DERIVATIVE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG METABOLISM; LIVER METABOLISM; MALARIA; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG DESIGN; ENZYMOLOGY; LIVER; LIVER MICROSOME; METABOLISM;

ANIMALS; ANTIMALARIALS; DRUG DESIGN; IMIDAZOLIDINES; LIVER; MICROSOMES, LIVER; PRIMAQUINE; RATS;

EID: 84864935570     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231212800229273     Document Type: Article

References (60)

1. Vale, N.; Moreira, R.; Gomes, P. Primaquine revisited: six decades after its discovery, Eur. J. Med. Chem., 2009, 44, 937-953.
2. Baird, J.K.; Wiady, I.; Sutanihardja, A.; Suradi; Purnmo; Basri, H.; Sekartuti; Ayomi, E.; Fryauff, D.J.; Hoffman, S.L. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am. J. Trop. Med. Hyg., 2002, 66, 659-660.
3. Pukrittayakamee, S.; Vanijanonta, S.; Chantra, A.; Clemens, R.; White, N.J.; Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J. Infect. Dis., 1994, 169, 932-935.
4. Taylor, W.R.; White, N.J. Antimalarial drug toxicity: a review, Drug Saf., 2004, 27, 25-61.
5. Hill, D.R.; Baird, J.K.; Parise, M.E.; Lewis, L.S.; Ryan, E.T.; Magill, A.J. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I, Am. J. Trop. Med. Hyg., 2006, 75, 402-415.
6. Percy, M.J.; McFerran, N.V.; Lappin, T.R. Disorders of oxidised haemoglobin. Blood Rev. 2005, 19, 61-68.
7. Cohen, R.J.; sachs, J.R.; Wicker, D.J.; Contrad, M.E.; Methemoglobinemia provoked by antimalarial chemoprophylaxis in Vietnam, N. Engl. J. Med., 1968, 279, 1127-1131.
8. Coleman, M.D.; Coleman, N.A., Drug-induced methemoglobinemia. Treatment issues. Drug Saf. 1996, 14, 394-405.
9. Ganesan, S.; Tekwani, B.L.; Sahu, R.; Tripathi, L.M.; Walker, L.A. Cytochrome P450-dependent toxic effects of primaquine on human erytrocytes. Toxicol. Appl. Pharmacol., 2009, 241, 14-22.
10. th Edition, Oxford University Press, 2009.
11. Constantino, L.; Paixão, P.; Moreira, R.; Portela, M.J.; Do Rosário, V.E.; Iley, J. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine. Exp. Toxicol. Pathol., 1999, 51, 299-303.
12. Mihaly, G.W.; Ward, S.A.; Edwards, G.; L'E Orme, M.; Breckenridge, A.M. Pharmacokinetic of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Braz. J. Clin. Pharmacol. 1984, 17, 441-446.
13. Baker, J.K.; McChesney, J.D.; Hufford, C.D.; Clarck, A.M. Highperformance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. J. Chromatogr. 1982, 230, 69-77.
14. Baker, J.K.; Bedford, J.A.; Clark, A.M.; McChesney, J.D. Metabolism and distribution of primaquine in monkeys. Pharm. Res., 1984, 1, 98-101.
15. Parkhurst, G.W.; Nora, M.V.; Thomas, R.W.; Carson, P.E. Highperformance liquid chromatographic ultraviolet determination of primaquine and its metabolites in human plasma and urine. J. Pharm. Sci., 1984, 73, 1329-1331.
16. Mihaly, G.W.; Ward, S.A.; Edwards, G.; Breckenridge, A.M. Pharmacokinetics of primaquine: identification of the carboxylic acid derivative as a major plasma metabolite. Br. J. Clin. Pharmacol., 1984, 17, 441-446.
17. Nora, M.V.; Parkhurst, G.W.; Thomas, R.W.; Carson, P.E. Highperformance liquid chromatographic-electrochemical assay method for primaquine in plasma and urine. J. Chromatogr., 1984, 307, 451-456.
18. Baker, J.K.; McChesney, J.D.; Walker, L.A. Excretion of metabolites in bile following the administration of primaquine to rats. Pharm. Res., 1985, 2, 231-233.
19. Frischer, H.; Mellovity, R.L.; Ahmad, T.; Nora, M.V. The conversion of primaquine into primaquine-aldehyde, primaquinealcohol, and carboxyprimaquine, a major plasma metabolite. J. Lab. Clin. Med., 1991, 117, 468-476.
20. R. P. Brueckner, C. Ohrt, J. K. Baird and W. K. Milhous, in Antimalarial Chemotherapy-mechanisms of action, resistance and new directions in drug discovery, Philip J. Rosenthal (Ed.), Humana Press, 2001.
21. Strother, A.; Allahyari, R.; Buchholz, J.; Fraser, I.M.; Tilton, B.E. In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite. Drug Metab. Dispos. 1984, 12, 35-44.
22. Fletcher, K.A.; Barton, P.F.; Kelly, J.A. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine. Biochem. Pharmacol. 1988, 37, 2683-2690.
23. Link, C.M.; Theoharides, A.D.; Anders, J.C.; Chung, H.; Canfield, C.J. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolyzates. Toxicol. Appl. Pharmacol., 1985, 81,192-202.
24. Allahyari, R.; Strother, A.; Fraser, I.M.; Verbiscar, A.J. Synthesis of certain hydroxy analogs of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes. J. Med. Chem., 1984, 27, 407-410.
25. Baird, J.K.; Davidson, D.E., Jr.; Decker-Jackson, J.E. Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro. Biochem. Pharmacol., 1986, 1, 1091-1098.
26. Agarwal, S.; Gupta, U.R.; Daniel, C.S.; Gupta, R.C.; Anand, N.; Agarwal, S.S., Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine, primaquine enantiomers, and its two putative metabolites. II. Effect on red blood cell membrane, lipid peroxidation, MC-540 staining, and scanning electron microscopic studies. Biochem Pharmacol., 1991, 41, 17-21.
27. Vásquez-Vivar, J.; Augusto, O. Hydroxylated metabolites of the antimalarial drug primaquine. J. Biol. Chem., 1992, 267, 6848-6854.
28. Baty, J.D.; Price-Evans, D.A.; Robinson, P.A. The identification of 6-methoxy 8-aminoquinoline as a metabolite of primaquine in man. Biomed. Mass Spectrom., 1975, 2, 304-306.
29. Bolchoz, L.J.C.; Budinsky, R.A.; McMillan, D.C.; Jollow, D.J. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J. Pharmacol. Exp. Ther., 2001, 297, 509-515.
30. Vale, N.; Matos, J.; Gut, J.; Nogueira, F.; do Rosário, V.; Rosenthal, P.J.; Moreira, R.; Gomes, P. Imidazolidin-4-one peptidomimetic derivatives of primaquine: synthesis and antimalarial activity. Bioorg. Med. Chem. Lett. 2008, 18, 4150-4153.
31. 1-acylation of imidazolidin-4-one derivatives of the antimalarial drug primaquine. Tetrahedron, 2008, 64, 11144-11149.
32. Vale, N.; Prudêncio, M.; Marques, C.A.; Collins, M.S.; Gut, J.; Nogueira, F.; Matos, J.; Rosenthal, P.J.; Cushion, M.T.; do Rosário, V.E.; Mota, M.M.; Moreira, R.; Gomes, P. Imidazoquines as antimalarial and anti-Pneumocystis agents. J. Med. Chem., 2009, 52, 7800-7807.
33. Fernandes, I.; Vale, N.; de Freitas, V.; Moreira, R.; Mateus, N.; Gomes, P. Anti-tumoral activity of imidazoquines, a new class of antimalarials derived from primaquine. Bioorg. Med. Chem. Lett., 2009, 19, 6914-6917.
34. Brandon, E.F.; Raap, C.D.; Meijerman, I.; Beijnen, J.H.; Schellens, J.H. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol., 2003, 189, 233-246.
35. Pfohl-Leszkowicz, A.; Pinelli, E.; Bartsch, H.; Mohr, U.; Castegnaro, M., Sex-and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog., 1998, 23, 76-85.
36. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem., 1976, 72, 248-54.
37. Pearce, R.; McIntyre, C.J.; Madan, A.; Sanzgiri, U.; Draper, A.J.; Bullock, P.; Cook, D.C.; Burton, L.A.; Latham, J.; Nevins, C.; Parkinson, A. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450. Arch. Biochem. Biophys., 1996, 331, 145-169.
38. Jia, L.; X. Liu. The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr. Drug Metabol., 2007, 8, 822-829.
39. Guldberg, H.C.; Marsden, C.A., Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol. Rev., 1975, 27, 135-206.
40. Tilgmann, C.; Kalkkinen, N., Purification and partial sequence analysis of the soluble catechol-O-methyltransferase from human placenta: Comparison to the rat liver enzyme. Biochem. Biophys. Res. Commun., 1991, 174, 995-1002.
41. Bertocci, B.; Miggiano, V.; Da Prada, M.; Dembic, Z.; Lahm, H.W.; Malherbe, P., Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 1416-1420.
42. Ulmanen, I.; Peränen, J.; Tenhunen, J.; Tilgmann, C.; Karhunen, T.; Panula, P.; Bernasconi, L.; Aubry, J. P.; Lundström, K., Expression and intracellular localization of catechol Omethyltransferase in transfected mammalian cells. Eur. J. Biochem., 1997, 243, 452-459.
43. Maennistoe, P. T.; Ulmanen, I.; Lundstroem, K.; Taskinen, J. Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog. Drug Res., 1992, 39, 291.
44. Tephly, T. R.; Burchell, B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci., 1990, 11, 276-279.
45. Lawrence, A.J.; Michalkiewicz, A.; Morley, J.S.; Mackinnon, K.; Billington, D. Differential inhibition of hepatic morphine UDPglucuronosyltransferases by metal ions. Biochem. Pharmacol., 1992, 43, 2335-2340.
46. Kauffman, F.C.; Bock, K. Conjugation-deconjugation reactions in drug metabolism and toxicity. Springer-Verlag: Berlin-Heidelberg, 1994.
47. Baker, J.K.; McChesney, J.D.; Jorge, L.F. Characterization of the urine metabolites of primaquine in rats. Pharm. Res. 1986, 3, 132-141.
48. Kaji, H.; Kume, T. Characterization of afloqualone Nglucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s). Drug Metabol. Dispos., 2005, 33, 60-67.
49. Ciotti, M.; Lakshmi, V.M.; Basu, N.; Davis, B.B.; Owens, I.S.; Zenser, T.V.; Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucoronides. Carcinogenesis, 1999, 20, 1963-1969.
50. Bass, R.; Ruddock, L. W.; Klappa, P.; Freedman, R. B. A major fraction of endoplasmic reticulum-located glutathione is present as mixed disulfides with protein. J. Biol. Chem., 2004, 279, 5257-5262.
51. Watt, K.C.; Morin, D.M.; Kurth, M.J.; Mercer, R.S.; Plopper, C.G.; Buckpitt, A.R. Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectrometry. Chem. Res. Toxicol., 1999, 12, 831-839.
52. Garg, A.; Prasad, B.; Takwani, H.; Jain, M.; Jain, R.; Singh, S. Evidence of the formation of direct covalent adducts of primaquine, 2-tert-butylprimaquine (NP-96) and monohydroxy metabolite of NP-96 with glutathione and N-acetylcysteine. J. Chrom. B, 2011, 879, 1-7.
53. Chambel, P.; Capela, R.; Lopes, F.; Iley, J.; Morais, J.; Gouveia, L.; Gomes, J. R. B.; Gomes, P.; Moreira, R. Reactivity of imidazolidin-4-one derivatives of primaquine: implications for prodrug design. Tetrahedron 2006, 62, 9883-9891.
54. Vale, N.; Matos, J.; Moreira, R.; Gomes, P. Electrospray ionization-ion trap mass spectrometry study of PQAAPro and PQProAA mimetic derivatives of the antimalarial primaquine. J. Am. Soc. Mass Spectrom. 2008, 19, 1476-1490.
55. Vale, N.; Nogueira, F.; do Rosário, V.; Gomes, P.; Moreira, R. Primaquine dipeptide derivatives bearing an imidazolidin-4-one moiety at the N-terminus as potential antimalarial prodrugs. Eur. J. Med. Chem. 2009, 44, 2506-2516.
56. Rosenberg, R. Plasmodium vivax in Africa: hidden in plain sight? Trends Parasitol. 2007, 23, 193-196.
57. Guerra, C.A.; Howes, R.E.; Patil, A.P.; Gething, P.W.; van Bioeckel, T.P.; Temperley, W.H.; Kabaria, C.W.; Tatem, A.J.; Manh, B.H.; Elyazar, I.R.F.; Baird, J.K.; Snow, R.W.; Hay, S.I. The international limits and population at risk of Plasmodium vivax transmission in 2009. PloS Neglected Trop. Dis. 2010, 4, e774.
58. Ménard, D.; Barnadas, C.; Bouchier, C.; Henry-Halldin, C.; Gray, L.R.; Rasimbasoa, A.; Thonier, V.; Carod, J.-F-; Domarle, O.; Colin, Y.; Bertrand, O.; Picot, J.; King, C.L.; Grimberg, B.T.; Mercereau-Puijalon, O.; Zimmerman, P. A. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. USA 2010, 107, 5967-5971.
59. Alexandre, M.A.; Ferreira, C.O.; Siqueira, A.; Magalhães, B.L.; Mourão, M.P.G.; Lacerda, M.V.; Alecrim, M.G.C. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerging Infect. Dis. 2010, 16, 1611-1614.
60. Peralta, P.S.-O.; Vazquez-Torres, M.C.; Latorre-Fandós, E.; Malral-Claver, P.; Cortina-Solano, P.; Puy-Azón, A.; Sancho, B.A.; Leltmeyer, K.; Lucientes-Curdi, J.; Sierra-Moros, M.J. first autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveill. 2010, 15, pii=19684.